| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d2f6c10a20fcaa16d79d88b1fc20f29e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da63996095bbeb7ce96b03cc989aa2dd |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y305-03006 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-50 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2015-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db7c70cf36cf54a11265ba32f54c7f26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94d38ecf4be9f39586850eb6c6dd6795
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_396de57b006a08bd5b298998b5d48f28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_963b9e51b8e0f57f8507346cbb4ed777
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89043069ffa93a43913132bd5cc2e51a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45d16a9c8605c4fdb6b023b05afb40d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5d53e8711a7d178e25a6c29d497b315 |
| publicationDate |
2018-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3193913-A4 |
| titleOfInvention |
Arginine deiminase with reduced cross-reactivity toward adi - peg 20 antibodies for cancer treatment |
| priorityDate |
2014-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |